Albireo
Clinical trials sponsored by Albireo, explained in plain language.
-
Promising new drug may ease severe itching in kids with rare liver disorder
Disease control CompletedThis study tested a medicine called A4250 in 62 children with progressive familial intrahepatic cholestasis (PFIC) types 1 and 2, a rare liver disease that causes severe itching and bile buildup. The goal was to see if the drug could lower bile acid levels and reduce scratching. …
Phase: PHASE3 • Sponsor: Albireo • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug shows promise for fatty liver in early trial
Disease control CompletedThis study tested an experimental drug called elobixibat in 47 adults with nonalcoholic fatty liver disease (NAFLD) or its more severe form, NASH. The main goal was to see if the drug could lower bad cholesterol (LDL-C) compared to a placebo over 16 weeks. Researchers also monito…
Phase: PHASE2 • Sponsor: Albireo • Aim: Disease control
Last updated May 19, 2026 11:59 UTC